Confidential Treatment Request means any confidential treatment request submitted to the Securities and Exchange Commission (the “SEC”) pursuant to Rule 406 of the Securities Act of 1933, as amended (the “1933 Act”) relating to certain exhibits to be filed with the Registration Statement.
Confidential Treatment Request means any confidential treatment request submitted to the Securities and Exchange Commission (the “SEC”) pursuant to Rule 406 of the Securities Act of 1933, as amended (the “1933 Act” or the “Securities Act”) relating to certain exhibits to be filed with the Registration Statement. “Investor” means the Investor identified above and any Affiliate or permitted transferee of the Investor who is a subsequent holder of Registrable Securities. “Prospectus” means (i) the prospectus included in any Registration Statement, as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement and by all other amendments and supplements to the prospectus, including post-effective amendments and all material incorporated by reference in such prospectus, and (ii) any “free writing prospectus” as defined in Rule 405 under the 1933 Act. “Register,” “registered” and “registration” refer to a registration made by preparing and filing a Registration Statement or similar document in compliance with the 1933 Act, and the declaration or ordering of effectiveness, or automatic effectiveness, of such Registration Statement or document. “Registrable Securities” means (A) the Shares acquired by Investor pursuant to the Purchase Agreement and (B) any other securities issued or issuable as a dividend or other distribution with respect to, in exchange for or in replacement of such Shares, whether by merger, charter amendment or otherwise; provided, that, a security shall cease to be a Registrable Security upon the earlier of (i) any sale, transfer, disposition or exchange pursuant to a Registration Statement and (ii) the date on which such Shares may be sold without retriction pursuant to Rule 144 under the 1933 Act and without compliance with Rule 144(c)(1). “Registration Statement” means any registration statement of the Company under the 1933 Act that covers the resale of any of the Registrable Securities pursuant to the provisions of
Confidential Treatment Request. The redacted material has been separately filed with the Commission."
Examples of Confidential Treatment Request in a sentence
These confidential terms have been omitted pursuant to a Confidential Treatment Request filed with the Securities and Exchange Commission ("SEC") and have been filed separately with the SEC.
These confidential terms have been omitted pursuant to a Confidential Treatment Request filed with the Securities and Exchange Commission ("SEC") pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, and have been filed separately with the SEC.
Portions marked [***] have been omitted pursuant to a Confidential Treatment Request by Symetra Financial Corp., this information has been filed separately with the Securities and Exchange Commission.
Portions marked [***] have been omitted pursuant to a Confidential Treatment Request by Symetra Financial Corporation, this information has been filed separately with the Securities and Exchange Commission.
These confidential terms have been omitted pursuant to a Confidential Treatment Request filed with the Securities and Exchange Commission (`SEC") and have been filed separately with the SEC.
More Definitions of Confidential Treatment Request
Confidential Treatment Request. The redacted material has been separately filed with the Commission." alternate index or substitute methodology for calculating the Price for such Product (the "Alternate Index"). If, on or before thirty (30) Days after the index used to determine the Price ceases to be available, the parties are unable to agree on an Alternate Index or substitute methodology upon which to base the calculation of the Price, the parties shall submit such determination to the alternative dispute resolution procedures set forth in Article XV hereinafter, which alternative dispute resolution procedures will determine the Alternate Index. From the date on which the index price used to determine the Price for a particular Product ceases to be available until the Alternate Index is determined, the Price for such Product shall be the average of the Prices in effect (or that would have been in effect) during the twelve (12) Months preceding the Month in which the index upon which the Price was based ceased to be available, which price shall be effective until the effective date of the Alternate Index determined as set forth in this Section 5.2. Upon the determination of an Alternate Index, the Price will be adjusted retroactively to the date on which the index upon which the Price previously was based ceased to be available.
Confidential Treatment Request. The redacted material has been separately filed with the Commission." warrants that WPC has the right to sell such Products and that such Products meet the quality specifications as set forth herein and is free from all liens, claims or other charges. UNLESS OTHERWISE PROVIDED IN THIS AGREEMENT, THERE ARE, NO OTHER WARRANTIES OF ANY KIND WHATSOEVER, EITHER EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, ANY WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE, MERCHANTABILITY, CONFORMITY TO MODELS OR SAMPLES, OR OTHERWISE, AND ALL SUCH WARRANTIES ARE HEREBY EXPRESSLY DISCLAIMED BY WPC AND EXCLUDED FROM THIS AGREEMENT.
Confidential Treatment Request. The redacted material has been separately filed with the Commission." EXHIBIT B Attached to and made a part of that certain CCC Product Sale and Purchase Agreement between Xxxxxx Petroleum Company, Limited Partnership and Chevron Chemical Company PRODUCT STORAGE AGREEMENT This Storage Agreement shall constitute our mutual agreement to lease certain Product storage space facilities owned or controlled by WPC.
Confidential Treatment Request. Confidential portion has been omitted and filed separately with the Commission. 41 APPENDIX D EARTH STATION AND OPERATIONAL REQUIREMENTS FOR ANALOG AND DIGITAL SERVICES VIA PAS-3 C-BAND AND KU-BAND TRANSPONDERS [ ]*
Confidential Treatment Request. Confidential portion has been omitted and filed separately with the Commission. 42 APPENDIX E
Confidential Treatment Request. Confidential portion has been omitted and file separately with the Commission.
Confidential Treatment Request. The portions of this document marked by "xxxxx" have been omitted pursuant to a request for confidential treatment and have been filed separately with the Securities and Exchange Commission XXXXX & XXXXXXXX ADVOCATES & SOLICITORS Dated 23 December 2004 CHARTERED SEMICONDUCTOR MANUFACTURING LTD. AS BORROWER and SUMITOMO MITSUI BANKING CORPORATION, SINGAPORE BRANCH ACTING AS LENDER FACILITY AGREEMENT XXXXX & XXXXXXXX XXX XXXXXX XXXXXXXXX #00-00 XXXXXXXXX 000000 TABLE OF CONTENTS